USPTO serial 87719667
CONFIDIAN
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- LAPTER, ALAIN J
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with CONFIDIAN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Justin L. Sage
Justin L. Sage Roche Diagnostics Operations, Inc.9115 Hague RoadIndianapolis, IN 46250UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | scientific, genomic and measuring apparatus, devices and instruments namely, automated sample handling equipment; apparatus, devices and instruments for identifying, sequencing, analyzing, measuring and/or recording DNA or other molecules for non-medical purposes namely, nucleic acid sequencers, imagers and analyzers; scientific instruments, namely, analyzers for detecting and karyotyping chromosomes; non-medical imaging device for visualizing DNA sequencing data; apparatus for preparation, amplification, mixing, hybridization, incubation, and washing of scientific samples namely, nucleic acid sample handler; laboratory apparatus, namely, nucleic acid sequencers; laboratory equipment, namely, genotyping and gene expression microarrays for analyzing nucleic acids for scientific, pharmaceutical and medical research purposes; computer software for use in the field of genome sequencing for analyzing, management and visualizing DNA sequencing data; bioinformatics computer software used to interpret results of genetic testing; computer systems and software for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, for use in the fields of scientific, diagnostic and clinical research and for clinical diagnostic purposes; computer software for use in analyzing, managing and visualizing DNA sequencing data; downloadable electronic publications, namely, datasheets and newsletters in the fields of molecular diagnostics and genetics | ACTIVE | — |
| 042 | scientific research and consultancy services related thereto in the fields of genetics; providing DNA screening and analysis for scientific research purposes; providing diagnostic services for others in the fields of science and medical research related thereto; Application service provider (ASP) featuring software for providing access to multiple databases that contain aggregated results of genotyping; application service provider (ASP) featuring software for use in the fields of genetics and genetic testing for scientific, diagnostic and clinical research and for clinical diagnostic purposes; consulting services in the field of cloud computing in the fields of life science; design and development of computer hardware and software for genetic testing, genetic sequencing, biochemical, laboratory research in the fields of biochemistry and medical genetics; computer services, namely, cloud hosting provider services for storing, analyzing and sharing data in the fields of life science; providing online non-downloadable software for the custom design and ordering of assays and reagents; design and development of laboratory instruments and computer systems for use in science and clinical research; consultancy, information and advisory services in the field of analysis of biomolecules biomolecules as it relates to DNA screening and genome sequence analysis and reporting | ACTIVE | — |
| 044 | medical services for genetic analysis; nucleic acid based testing for medical purposes; medical services in the field of nucleic acid analysis; providing molecular genetic diagnostic; mutation carrier diagnostics in the newborns and adults | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Roche Molecular Systems, Inc.
- Other trademarks owned by Roche Molecular Systems, Inc.
- Other trademarks in Class 009
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CONFIDIAN
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 8, 2021 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Feb 8, 2021 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 19, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 19, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 19, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 19, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 19, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 3, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 1, 2020 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Jul 1, 2020 | EXT4 | SOU EXTENSION 4 FILED | — |
| Jul 1, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 20, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 18, 2019 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Dec 18, 2019 | EXT3 | SOU EXTENSION 3 FILED | — |
| Dec 18, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 27, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 27, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 2, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 2, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 4, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 2, 2019 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jul 2, 2019 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jul 2, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 9, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 9, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 4, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 2, 2019 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jan 2, 2019 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jan 2, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 3, 2018 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 8, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 8, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 18, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 4, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 26, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 26, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 22, 2018 | ALIE | ASSIGNED TO LIE | — |
| Mar 12, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 14, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 14, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 14, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 12, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 27, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 16, 2017 | NWAP | NEW APPLICATION ENTERED | — |